Nationwide Fund Advisors Meridian Bioscience Inc Transaction History

Nationwide Fund Advisors

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 01, 2018
SELL
$13.55 - $15.8 $2.39 Million - $2.79 Million
-176,550 Closed
0 $0
Q3 2017

Oct 23, 2017
SELL
$13.45 - $14.35 $11,244 - $11,996
-836 Reduced 0.47%
176,550 $2.53 Million
Q2 2017

Aug 10, 2017
BUY
N/A
177,386
177,386 $2.79 Million

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Nationwide Fund Advisors Portfolio

Follow Nationwide Fund Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Nationwide Fund Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email